Abbvie Inc

NYSE:ABBV   10:55:47 AM EDT
116.30
-0.59 (-0.50%)
Products

U.S. FDA Accepts Abbvie's New Drug Application For Atogepant For The Preventive Treatment Of Migraine

Published: 03/30/2021 12:29 GMT
Abbvie Inc (ABBV) - U.S. FDA Accepts Abbvie's New Drug Application for Atogepant for the Preventive Treatment of Migraine.